Acadia Healthcare Company Inc.

70.37+1.87+2.73%Vol 600.70K1Y Perf 7.18%
Jun 24th, 2022 16:00 DELAYED
BID69.86 ASK70.69
Open69.31 Previous Close68.50
Pre-Market- After-Market70.37
 - -  - -%
Target Price
79.42 
Analyst Rating
Moderate Buy 2.00
Potential %
12.86 
Finscreener Ranking
★★     46.23
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★★     52.05
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★     47.04
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
76.26 
Earnings Rating
Buy
Market Cap6.37B 
Earnings Date
1st Aug 2022
Alpha0.01 Standard Deviation0.13
Beta1.28 

Today's Price Range

68.7770.65

52W Range

50.0776.69

5 Year PE Ratio Range

-12.50603.80

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
8.43%
1 Month
-2.32%
3 Months
6.80%
6 Months
19.03%
1 Year
7.18%
3 Years
104.27%
5 Years
46.51%
10 Years
317.63%

TickerPriceChg.Chg.%
ACHC70.371.87002.73
AAPL141.663.39002.45
GOOG2 370.76117.07005.19
MSFT267.708.84003.41
XOM86.901.69001.98
WFC40.762.86007.55
JNJ182.292.63001.46
FB196.640.99000.51
GE67.083.01004.70
JPM117.323.40002.98
Financial StrengthValueIndustryS&P 500US Markets
1.20
1.30
0.38
0.63
6.10
Leverage Ratio 1.90
ProfitabilityValueIndustryS&P 500US Markets
42.50
16.40
21.00
6.30
10.38
RevenueValueIndustryS&P 500US Markets
2.38B
26.29
-9.67
-5.38
Earnings HistoryEstimateReportedSurprise %
Q01 20220.630.676.35
Q04 20210.680.67-1.47
Q03 20210.720.720.00
Q02 20210.630.7112.70
Q01 20210.450.474.44
Q04 20200.691.1363.77
Q03 20200.550.6823.64
Q02 20200.380.5442.11
Earnings Per EndEstimateRevision %Trend
6/2022 QR0.791.28Positive
9/2022 QR0.800.00-
12/2022 FY3.093.34Positive
12/2023 FY3.350.30Positive
Next Report Date1st Aug 2022
Estimated EPS Next Report0.79
Estimates Count5
EPS Growth Next 5 Years %12.50
Volume Overview
Volume600.70K
Shares Outstanding90.53K
Shares Float78.16M
Trades Count11.19K
Dollar Volume42.09M
Avg. Volume544.95K
Avg. Weekly Volume525.14K
Avg. Monthly Volume465.07K
Avg. Quarterly Volume644.64K

Acadia Healthcare Company Inc. (NASDAQ: ACHC) stock closed at 70.37 per share at the end of the most recent trading day (a 2.73% change compared to the prior day closing price) with a volume of 600.70K shares and market capitalization of 6.37B. Is a component of Russell 1000 indices and it is traded on NASDAQ exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 42800 people. Acadia Healthcare Company Inc. CEO is Debra K. Osteen.

The one-year performance of Acadia Healthcare Company Inc. stock is 7.18%, while year-to-date (YTD) performance is 15.93%. ACHC stock has a five-year performance of 46.51%. Its 52-week range is between 50.07 and 76.69, which gives ACHC stock a 52-week price range ratio of 76.26%

Acadia Healthcare Company Inc. currently has a PE ratio of 24.40, a price-to-book (PB) ratio of 2.28, a price-to-sale (PS) ratio of 2.47, a price to cashflow ratio of 15.80, a PEG ratio of 2.32, a ROA of 5.16%, a ROC of 7.13% and a ROE of 9.92%. The company’s profit margin is 10.38%, its EBITDA margin is 21.00%, and its revenue ttm is $2.38 Billion , which makes it $26.29 revenue per share.

Of the last four earnings reports from Acadia Healthcare Company Inc., there were 2 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $0.79 for the next earnings report. Acadia Healthcare Company Inc.’s next earnings report date is 01st Aug 2022.

The consensus rating of Wall Street analysts for Acadia Healthcare Company Inc. is Moderate Buy (2), with a target price of $79.42, which is +12.86% compared to the current price. The earnings rating for Acadia Healthcare Company Inc. stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Acadia Healthcare Company Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Acadia Healthcare Company Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 11.31, ATR14 : 2.36, CCI20 : 38.14, Chaikin Money Flow : 0.05, MACD : -0.54, Money Flow Index : 55.14, ROC : -1.08, RSI : 55.40, STOCH (14,3) : 84.08, STOCH RSI : 1.00, UO : 66.20, Williams %R : -15.92), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Acadia Healthcare Company Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
6 (60.00 %)
6 (66.67 %)
6 (60.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
3 (30.00 %)
2 (22.22 %)
3 (30.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
1 (10.00 %)
1 (11.11 %)
1 (10.00 %)
Summary RatingModerate Buy
2.00
Moderate Buy
1.89
Moderate Buy
2.00

Acadia Healthcare Company Inc.

Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities in the United States, United Kingdom, and Puerto Rico. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The U.S. facilities receive the largest proportion of payments from Medicaid, with the second largest proportion from commercial payors. In the United Kingdom, the majority of Acadia's revenue comes from its healthcare facilities, and virtually all of the payment received is from the National Health Service.

CEO: Debra K. Osteen

Telephone: +1 615 861-6000

Address: 6100 Tower Circle, Franklin 37067, TN, US

Number of employees: 42 800

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

54%46%

Bearish Bullish

64%36%

Bearish Bullish

61%39%

News

Stocktwits